Biomarkers can speed R&D by predicting toxicity; AD biomarkers change with age;

> Drug pipelines are shrinking, and the costs of drug development are climbing. Biomarkers can speed development by predicting toxicity, and a study in Molecular & Cellular Proteomics has created a "roadmap" to verify markers. Press release | Abstract

> According to research presented at the Alzheimer's Association International Conference, relationships between inflammation markers and dementia risk change with age in elderly and very elderly people. Article

> Chip can detect 8 different biomarkers to improve oral cancer detection. Article

> EKF Diagnostics has licensed kidney biomarkers from the Joslin Diabetes Center. Agreement

> New genetic variants could predict risk of breast cancer. Abstract

> Halo Healthcare has signed an agreement with the University of North Dakota to develop biomarkers for the early detection of breast cancer. Press release

> Expression of the MCM3 gene and protein could predict prognosis in malignant melanoma. Abstract

> Agilent Technologies and Gachon University of Medicine and Science are collaborating over biomarkers for cancer and diabetes. Press release

And Finally… Conjunctival ultraviolet autofluorescence (UVAF), which is a biomarker of outdoor light exposure, protects against myopia (short sight)--so perhaps your mother was right when she told you to stop reading a book and go play outside! Abstract

Suggested Articles

The AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.